Blume, K.G., Forman, S.J. and Appelbaum, F.R. Editors. Hematopoietic Cell Transplantation, 3rd edition. London: Blackwell Publishing Ltd., London, England 2004.
Nademanee A, Forman SJ. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B. Semin Hematol. 2006 Oct;43(4):240-50. Review.
Numbenjapon T, Serrano LM, Singh H, Kowolik CM, Olivares S, Gonzalez N, Chang WC, Forman SJ, Jensen MC, Cooper LJ. Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells. Leukemia. 2006 Oct;20(10):1889-92. No abstract available.
Lacey SF, La Rosa C, Zhou W, Sharma MC, Martinez J, Krishnan A, Gallez-Hawkins G, Thao L, Longmate J, Spielberger R, Forman SJ, Limaye A, Zaia JA, Diamond DJ. Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients. J Infect Dis. 2006 Nov 15;194(10):1410-21. Epub 2006 Oct 11.
Snyder DS, Palmer J, Stein AS, Pullarkat V, Sahebi F, Cohen S, Vora N, Gaal K, Nakamura R, Forman SJ. Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis. Biol Blood Marrow Transplant. 2006 Nov;12(11):1161-8.
Kowolik CM, Topp MS, Gonzalez S, Pfeiffer T, Olivares S, Gonzalez N, Smith DD, Forman SJ, Jensen MC, Cooper LJ. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. Cancer Res. 2006 Nov 15;66(22):10995-1004.
Rodriguez R, Nademanee A, Ruel N, Smith E, Krishnan A, Popplewell L, Zain J, Patane K, Kogut N, Nakamura R, Sarkodee-Adoo C, Forman SJ. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 2006 Dec;12(12):1326-34.
Zhang, C., Todorov, I., Zhang, A., Liu, Y., Kandeel, F., Forman, S., Strober, S., Zeng, D. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood, 107:2993-3001, 2006.
Nademanee, A., Forman, S.J., Molina, A., Fung, H., Smith, D., Dagis, A., Kwok, C., Yamauchi, D., Anderson, A., Falk, P., Krishnan, A., Kirschbaum, M., Kogut, N., Nakamura, R., O’Donnell, M., Parker, P., Popplewell, L., Pullarkat, V., Rodriguez, R., Sahebi, F., Smith, E., Snyder, D., Stein, A., Spielberger, R., Zain, J., White, C., and Raubitschek, A. A phase ½ trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma. Blood, 106:2896, 2005.
Cooper, L.J., Al-Kadhimi, Z., Serrano, L.M., Pfeiffer, T., Olivares, S., Castro, A., Chang, W.C., Gonzalez, S., Smith, D., Forman, S.J., and Jensen, M.C. Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1. Blood, 105:1622, 2005.
Krishnan, A., Molina, A., Zaia, J., Smith, D., Vasquez, D., Kogut, N., Falk, P.M., Rosenthal, J., Alvarnas, J., and Forman, S.J. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood, 105:874, 2005.
Stein, A.S., O’Donnell, M.R., Slovak, M.L., Snyder, D.S., Nademanee, A.P., Parker, P., Molina, A., Somlo, G., Fung, H.C., Krishnan, A., Rodriguez, R., Spielberger, R.T., Wang, S., Dagis, A., Vora, N., Arber, D.A., Niland, J.C., Forman, S.J. Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. Journal of Clinical Oncology, 21:615, 2003.
Bhatia, R., Holtz, M., Niu, N., Gray, R., Snyder, D.S., Sawyers, C.L., Arber, D.A., Slovak, M.L., and Forman, S.J. Persistence of malignant Hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood, 101:4701, 2003.
Shih, C., Weng, Y., Mamelak, A., LeBon, T. and Forman, S.J. Identification of a candidate human neurohematopoietic stem-cell population. Blood, 98:2412, 2001.
Gillies, S., Lan, Y., Williams, S., Carr, F., Forman, S.J., Raubitschek, A. and Lo, K.M. An anti-CD20-IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma. Blood, 105:3972-78, 2005.
Holtz, M.S., Forman, S.J. and Bhatia, R. Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia, 19:1034-41, 2005.
Lacey, S.F., Martinez, J., Gallez-Hawkins, G., Thao, L., Longmate, J., Haq, W., Spielberger, R., Forman, S.J., Zaia, J. and Diamond, D. Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem cell transplant recipients. Journal of Infectous Disease, 191:977-84, 2005.
Cooper, LJN., Al-Kadhimi, Z., Serrano, L., Pfeiffer, T., Olivares, S., Castro, A., Chang, W-C., Gonzalez, S., Smith, D., Forman, S.J., and Jensen, M.C. Enhanced anti-lymphoma efficacy of CD-19 redirected influenza-specific CTL’s by co-transfer of t-cells modified to express influenza MP-1. Blood, 105:1622-31, 2005.
Bhatia R, Holtz M, Niu N, Gray R, Snyder DS, Sawyers CL, Arber DA, Slovak ML, Forman SJ. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood, 101:4701-7, 2003.
Cooper, L.J.N., Topp, M.S., Serrano, L.M., Gonzalez, S., Chang, W.-C., Wright, C., Popplewell, L., Raubitschek, A., Forman, S.J., and Jensen, M.C. T cell clones can be rendered specific for CD19: Toward the selective augmentation of the graft versus B-lineage leukemia effect. Blood, 101:1637-44, 2003.
Stein, A.S., O’Donnell, M.R., Slovak, M.S., Snyder, D., Nademanee, A., Parker, P., Molina, A., Somlo, G., Fung, H.C., Krishnan, A., Rodriguez, R., Spielberger, R.T., Wang, S., Dagis, A., Vora, N., Arber, D.A., Niland, J.C. and Forman, S.J. Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J of Clinical Oncology, 21:615-23, 2003.
Bensinger, W., Martin, P., Storer, B., Clift, R., Forman, S.J., Negrin, R., Kashyap, A., Flowers, M.E.D., Lilleby, K., Chauncey, T.R., Storb, R. and Appelbaum, F.R. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic malignancies. NEJM, 344:175-181, 2001.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported. Last updated: 07/08.
